- OUTLOOK
The global fight against hepatitis B is benefitting some parts of the world more than others

Illustration: Chiara Zarmati
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 603, S58-S59 (2022)
doi: https://doi.org/10.1038/d41586-022-00818-9
This article is part of Nature Outlook: Hepatitis B, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Stockdale, A. J. et al. J. Infect. Dis. https://doi.org/10.1093/infdis/jiab562 (2021).
Kane, M. A. et al. Vaccine 31, J15–J20 (2013).
Qu, C., Duan, Z., Chen, K. & Zou, H. Hepatoma Res. 3, 228–240 (2017).
Tordrup, D. et al. Lancet Glob. Health 7, e1180-e1188 (2019).
Tordrup, D. et al. Value Health 23, 1552–1560 (2020).
Toy, M., Hutton, D. W. & So, S. Health Aff. 37, 1033–1040 (2018).
Toy, M. et al. Clin. Infect. Dis. 74, 210–217 (2022).